Page 411 - Cardiac Nursing

Pa
Pa
M
M
g
e 3
e 3
g
g
/09
1
/30
/09
1
6 A
6 A
2:1
2:1
87
a
a
ara
ara
In
c.
c.
In
c.
A
A
87
A
p
t
t
p
p
K34
K34
33
LWBK340-c16_ p pp333-387.qxd 6/30/09 12:16 AM Page 387 Aptara Inc.
LWB
LWB
16_
16_
0-c
33
p
0-c
3-3
q
6
6
6
xd
xd
/30
87.
3-3
87.
q
q
C HAPTER 16 / Arrhythmias and Conduction Disturbances 387
Gillis, A. M. (2004). Class I antiarrhythmic drugs: Quinidine, procainamide, Opie, L. H., & Gersh, B. J. (2005). Drugs for the heart (6th ed.). Philadelphia:
disopyramide, lidocaine, mexiletine, flecainide, and propafenone. In D. P. Elsevier Saunders.
Zipes & J. Jalife (Eds.), Cardiac electrophysiology: From cell to bedside (4th Roden, D. M. (2006). Antiarrhythmics. In L. L. Brunton (Ed.), Goodman and
ed., pp. 911–917). Philadelphia: Saunders. Gilman’s the pharmacological basis of therapeutics (11th ed., pp. 899–932).
Miller, J. M., & Zipes, D. P. (2008). Therapy for cardiac arrhythmias. In New York: McGraw-Hill.
P. Libby, R. O. Bonow, D. L. Mann, et al. (Eds.), Braunwald’s heart dis- Singh, B. N. (2004). Beta blockers and calcium channel blockers as antiar-
ease: A textbook of cardiovascular medicine (pp. 779–830). Philadelphia: rhythmic drugs. In D. P. Zipes & J. Jalife (Eds.), Cardiac electrophysiology:
Saunders. From cell to bedside (4th ed., pp. 918–931). Philadelphia: Saunders.
Naccarelli, G. V., Sager, P. T., & Singh, B. N. (2001). Antiarrhythmic agents. Smith, T. W., & Cain, M. E. (2004). Class III antiarrhythmic drugs: Amio-
In P. J. Podrid & P. R. Kowey (Eds.), Cardiac arrhythmia: Mechanisms, di- darone, ibutilide, and sotalol. In D. P. Zipes & J. Jalife (Eds.), Cardiac elec-
agnosis, and management (2nd ed., pp. 265–301). Philadelphia: Lippincott trophysiology: From cell to bedside (4th ed., pp. 932–941). Philadelphia:
Williams & Wilkins. Saunders.